UNIVERSITY SKIN SPECIALIST
SPIN-OUT AIMS HIGH WITH
£4.5M FLOAT
Skin health company, SkinBioTherapeutics (AIM:SBTX)
will focus on developing and commercialising its
SkinBiotix
®
technology platform after making a stunning
debut on the London stock market.
The images show human
skin which has been
stained with a green dye to
visualise a protein, critical
to skin function as a barrier
between the body and
the environment. The level
of this protein increases
dramatically following
treatment with a
particular bacterium
Untreated
UMIP HIGHLIGHTS
Treated
